Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Boiron SA (Boiron) is a pharmaceutical company. It develops, manufactures and commercializes homeopathic medicines. The company operates through two reportable business segments, namely, Non-proprietary homeopathic medicines, associated with precise therapeutic indications and dosage; and OTC specialties, no specific therapeutic indication or dosage. Its product portfolio comprises Camilia, Euphralia, Arnigel, Oscillococcinum, Sedatif PC, Homeoptic and Stodal.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2


Section 1 - About the Company 6
Boiron SA - Key Facts 6
Boiron SA - Key Employees 7
Boiron SA - Key Employee Biographies 8
Boiron SA - Major Products and Services 9
Boiron SA - History 10
Boiron SA - Company Statement 12
Boiron SA - Locations And Subsidiaries 13
Head Office 13
Other Locations and Subsidiaries 13
Section 2 - Company Analysis 15
Boiron SA - Business Description 15
Boiron SA - SWOT Analysis 16
SWOT Analysis - Overview 16
Boiron SA - Strengths 16
Strength - Advanced RandD Activities 16
Strength - Widespread Geographic Presence 16
Boiron SA - Weaknesses 16
Weakness - Legal Proceedings 16
Boiron SA - Opportunities 16
Opportunity - Changing Demographics 16
Opportunity - Market Potential: Homeopathy 17
Boiron SA - Threats 17
Threat - Prejudice Against Homeopathy 17
Threat - Uncertain RandD Outcomes 17
Boiron SA - Key Competitors 18
Section 3 - Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 - Company's Lifesciences Financial Deals and Alliances 25
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26
Boiron SA, Recent Deals Summary 27
Section 5 - Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Boiron SA, Key Facts 6
Boiron SA, Key Employees 7
Boiron SA, Key Employee Biographies 8
Boiron SA, Major Products and Services 9
Boiron SA, History 10
Boiron SA, Subsidiaries 13
Boiron SA, Key Competitors 18
Boiron SA, Ratios based on current share price 19
Boiron SA, Annual Ratios 20
Boiron SA, Interim Ratios 23
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26
Boiron SA, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Boiron SA, Performance Chart (2009 - 2013) 22
Boiron SA, Ratio Charts 24
Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25
Boiron SA, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 26

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.